In recent months, the government has imposed price controls on coronary stents, orthopedic implants and several drugs. On the other hand, healthcare companies are seeing inflationary pressures on their costs. How can companies balance these pressures without impacting quality? A panel of healthcare industry officials and private equity executives discussed these issues at the VCC Healthcare Investment Summit 2017, held in Mumbai in September. Watch the video to know more.
Like this video? Sign up for our daily newsletter to get our top reports & videos.